The skin gateway
to the Immune System

What's New ?

August, 26 2014


DBV Technologies to Attend the Goldman Sachs European Biotech Symposium

DBV Technologies to Attend the Goldman Sachs European Biotech Symposium
                
                
BAGNEUX, France, August 26, 2014 - DBV Technologies, (Euronext: DBV - ISIN: FR0010417345), creator of Viaskin®, today announced that the Company's management will be hosting investor meetings during the Goldman Sachs European Biotech Symposium to be held in London on Friday, September 5, 2014.

More

Events

No entries

A revolutionary approach in allergy treatment

11 to 26 million people suffer from food allergy in Europe while at the global level, the estimate is 220 to 500 million people. 3 to 5% of Americans suffer from food allergies and the prevalence of peanut allergy in children has almost quadrupled from 1997 to 2008…

EPIT Method Video

Missing flash plugin. Please download the latest Adobe Flash Player:
Get Adobe Flash Player

A short animation film explaining how DBV uses the Epicutaneous Immunotherapy with its VIASKIN patch to desensitize allergic patients

Legal Mention

CNIL number: 1544201 v 0

DBV technologies - siège social
Green Square - Bâtiment D
80/84 rue des Meuniers
92220 Bagneux
France
Phone: +33 (0)1 55 42 78 78
Fax: +33 (0)1 43 26 10 83

SIRET: 441772522 00013
RCS: Nanterre

Executive editor: Pierre-Henri Benhamou

Hosting service: OVH www.ovh.com

Design : l’enchanteur www.lenchanteur.com

Contact


Terms of Use


Forward-Looking Statements.

This website contains express or implied forward-looking statements, which are based on current expectations of management. These statements relate to, among other things, our expectations regarding management’s plans, objectives, and strategies. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. DBV assumes no obligation to update any forward-looking statements appearing on this website in the event of changing circumstances or otherwise, and such statements are current only as of the date they are made.



Updates.

DBV may make improvements and/or changes to this website at any time. Although we attempt to periodically update information on this website, the information, materials and services provided on or through this website may occasionally be inaccurate, incomplete or out of date. DBV does not have a duty to update information contained in this website, and DBV will not be liable for any failure to update such information. We make no representation as to the completeness, accuracy or currency of any information on this website, and we undertake no obligation to update or revise the information contained on this website, whether as a result of new information, future events or circumstances or otherwise. It is your responsibility to verify any information contained in this website before relying upon it.



Links.

This website may contain links to websites operated by other parties. The linked sites are not under the control of DBV, and DBV is not responsible for the content available on any other Internet sites linked to this website. Such links do not imply DBV’s endorsement of material on any other site, and DBV disclaims all liability with regard to your access to such linked websites. DBV provides links to other Internet sites as a convenience to users, and access to any other Internet sites linked to this website is at your own risk.